Bessemer Group
ROIV icon

Bessemer Group’s Roivant Sciences ROIV Stock Holding History

Bessemer Group’s Portfolio ROIV Stock Details ROIV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$103K Buy
2,899
+434
+18% +$12.8K ﹤0.01% 1522
2026
Q1 		$69K Buy
2,465
+441
+22% +$11.3K ﹤0.01% 1589
2025
Q4 		$44K Buy
2,024
+172
+9% +$3.39K ﹤0.01% 1672
2025
Q3 		$28K Buy
1,852
+543
+41% +$6.72K ﹤0.01% 1595
2025
Q2 		$15K Buy
1,309
+310
+31% +$3.36K ﹤0.01% 1667
2025
Q1 		$10K Buy
999
+63
+7% +$681 ﹤0.01% 1784
2024
Q4 		$11K Buy
936
+826
+751% +$9.77K ﹤0.01% 1737
2024
Q3 		$1K Buy
+110
New +$1.25K ﹤0.01% 2522

Other funds holding ROIV

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
QF
QVT Financial New York $1.7B AUM 173.77% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return

Bessemer Group's ROIV Position: Q2 2026 in Review

Bessemer Group increased its Roivant Sciences (ROIV) stake by 18% in Q2 2026, buying an estimated $12.8K and bringing the position to 2,899 shares worth $103K. The position accounts for ﹤0.01% of the portfolio, ranked #1522.

Bessemer Group first reported a position in ROIV in Q3 2024 and has held it in 8 quarters since. 498 funds tracked by Wall St. Rank hold ROIV as of Q2 2026.

  • Bessemer Group held 2,899 shares of Roivant Sciences worth $103K as of Q2 2026.
  • Bessemer Group bought 434 Roivant Sciences shares in Q2 2026, an estimated $12.8K.
  • Roivant Sciences made up ﹤0.01% of Bessemer Group's portfolio in Q2 2026, its #1522 holding.
  • Bessemer Group first reported a position in Roivant Sciences in Q3 2024 and has held it in 8 quarters since.
  • 498 funds tracked by Wall St. Rank held Roivant Sciences as of Q2 2026.

Based on Bessemer Group's 13F filing for Q2 2026, filed 12 Aug 2026.